21st Jun 2006 10:54
Dechra Pharmaceuticals PLC21 June 2006 DECHRA PHARMACEUTICALS PLC (the "Company") PDMR SHAREHOLDING The Company was informed on 20 June 2006 that Mr M Annice, the Managing Directorof Dales Pharmaceuticals, a division of Dechra Pharmaceuticals PLC, has todayexercised SAYE options over 14,538 ordinary shares of 1p each in the Company("Ordinary Shares") at a price of 39 pence per Ordinary Share. Following thistransaction, Mr Annice's beneficial interest is 610,872 Ordinary Shares,representing approximately 1.18 per cent. of the Company's issued ordinary sharecapital. 21 June 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L